2024 Q3 Form 10-K Financial Statement

#000107997324001330 Filed on August 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2024
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $13.23K $145.9K
YoY Change -76.83% -40.55%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $32.69K $13.23K $145.8K
YoY Change -56.15% -76.83% -40.55%
Operating Profit -$32.69K -$145.8K
YoY Change -56.15% -40.55%
Interest Expense $132.3K -$127.4K $526.4K
YoY Change 0.0% 0.19% 0.27%
% of Operating Profit
Other Income/Expense, Net -$127.4K -$505.9K
YoY Change 0.89% -1.84%
Pretax Income -$140.7K -$651.7K
YoY Change -23.68% -14.32%
Income Tax
% Of Pretax Income
Net Earnings -$160.1K -$140.7K -$651.7K
YoY Change -20.28% -23.68% -14.32%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 107.5M shares 107.5M shares 107.5M shares
Diluted Shares Outstanding 107.5M shares 107.5M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $764.2K $764.2K
YoY Change -14.08% -14.08%
Cash & Equivalents $741.6K $764.2K
Short-Term Investments
Other Short-Term Assets $490.00 $490.00
YoY Change -16.95% -16.95%
Inventory
Prepaid Expenses $187.00 $487.00
Receivables
Other Receivables
Total Short-Term Assets $741.7K $764.7K $764.7K
YoY Change -10.13% -14.08% -14.08%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $741.7K $764.7K $764.7K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $741.7K $764.7K $764.7K
YoY Change -10.13% -14.08% -14.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.050K $100.00 $100.00
YoY Change 1.25% 0.0% 0.0%
Accrued Expenses $875.00 $3.521M $3.521M
YoY Change -99.97% 17.58% 17.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.658M $3.521M $3.521M
YoY Change -35.03% -35.92% -35.92%
LONG-TERM LIABILITIES
Long-Term Debt $10.50M $10.50M
YoY Change 31.25% 31.25%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $10.50M $10.50M
YoY Change 31.25% 31.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.658M $3.521M $3.521M
Total Long-Term Liabilities $10.50M $10.50M
Total Liabilities $14.16M $14.02M $14.02M
YoY Change 3.87% 3.9% 3.9%
SHAREHOLDERS EQUITY
Retained Earnings -$18.69M -$18.53M
YoY Change 3.38% 3.65%
Common Stock $107.5K $107.5K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.42M -$13.26M -$13.26M
YoY Change
Total Liabilities & Shareholders Equity $741.7K $764.7K $764.7K
YoY Change -10.13% -14.08% -14.08%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2024
OPERATING ACTIVITIES
Net Income -$160.1K -$140.7K -$651.7K
YoY Change -20.28% -23.68% -14.32%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$22.65K -$7.170K -$125.2K
YoY Change -71.37% -89.34% -50.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$22.65K -7.170K -$125.2K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -$22.65K -7.170K -$125.2K
YoY Change -71.37% -89.34% -50.11%
FREE CASH FLOW
Cash From Operating Activities -$22.65K -$7.170K -$125.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
107483450 shares
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001616156
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-05-31
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
000-55957
CY2024 dei Entity Registrant Name
EntityRegistrantName
WEWARDS, INC.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-1230099
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
3305 Spring Mountain Road
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 104
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89102
CY2024 dei City Area Code
CityAreaCode
702
CY2024 dei Local Phone Number
LocalPhoneNumber
944-5599
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
13486000 usd
CY2024 dei Auditor Firm
AuditorFirmId
2738
CY2024 dei Auditor Name
AuditorName
M&K CPAS, PLLC
CY2024 dei Auditor Location
AuditorLocation
Houston, TX
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
764205 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
889405 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
487 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
587 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
764692 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
889992 usd
CY2024Q2 us-gaap Assets
Assets
764692 usd
CY2023Q2 us-gaap Assets
Assets
889992 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
100 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
100 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2994467 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2500000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3521006 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5494567 usd
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
10500000 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8000000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
14021006 usd
CY2023Q2 us-gaap Liabilities
Liabilities
13494567 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107483450 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
107483 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
107483 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5161532 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5161532 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18525329 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17873590 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-13256314 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12604575 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
764692 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
889992 usd
CY2024 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8218 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2839 usd
CY2024 WEWA Rent Expense
RentExpense
75113 usd
CY2023 WEWA Rent Expense
RentExpense
180000 usd
CY2024 us-gaap Professional Fees
ProfessionalFees
62515 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
62492 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
145846 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
245331 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-145846 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-245331 usd
CY2024 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
526439 usd
CY2023 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
525000 usd
CY2024 us-gaap Interest Income Other
InterestIncomeOther
20546 usd
CY2023 us-gaap Interest Income Other
InterestIncomeOther
9641 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-505893 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-515359 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-651739 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-760690 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107483450 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107483450 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-11843885 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-760690 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12604575 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-651739 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-13256314 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-651739 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-760690 usd
CY2024 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-100 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
287 usd
CY2024 WEWA Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-0 usd
CY2023 WEWA Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-130608 usd
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15000 usd
CY2024 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
526439 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
525000 usd
CY2024 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-130608 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-125200 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-250977 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-125200 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-250977 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
889405 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1140382 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2015Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
6000000 shares
CY2015Q2 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.738 pure
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8130000 shares
CY2015Q2 WEWA Sale Of Stock Number Of Share Issued In Transaction
SaleOfStockNumberOfShareIssuedInTransaction
340000 usd
CY2015Q2 WEWA Number Of Common Shares Sold Through Stock Purchase Agreement
NumberOfCommonSharesSoldThroughStockPurchaseAgreement
6000000 shares
CY2020Q2 WEWA Cash Consideration For Intellectual Property
CashConsiderationForIntellectualProperty
179300 usd
CY2022 WEWA Monthly Fees
MonthlyFees
168500 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1622500 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_z2Tk2tKDOKqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86A_zhKu9eiUFdf2">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zOMcN1g1lzT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_867_zo42vO85dDud">Concentrations of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_90C_eus-gaap--CashFDICInsuredAmount_iI_c20240531_ztQzfA5qBPcc" title="FDIC insured amount">250,000</span> under current regulations. The Company had approximately $<span id="xdx_904_eus-gaap--CashUninsuredAmount_pp0p0_c20240531_zXBeuv9dNDTc" title="Excess of FDIC insured limits">514,205</span> and $<span id="xdx_90E_eus-gaap--CashUninsuredAmount_pp0p0_c20230531_zZwfrtwTvV9i" title="Excess of FDIC insured limits">640,755</span> in excess of FDIC insured limits at May 31, 2024 and 2023, respectively. The Company has not experienced any losses in such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
514205 usd
CY2023Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
640755 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18525329 usd
CY2024Q2 WEWA Working Capital
WorkingCapital
-2756314 usd
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
10500000 usd
CY2023Q2 us-gaap Convertible Debt
ConvertibleDebt
10500000 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2500000 usd
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
10500000 usd
CY2023Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8000000 usd
CY2024 us-gaap Interest Expense
InterestExpense
526439 usd
CY2023 us-gaap Interest Expense
InterestExpense
525000 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107483450 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107483450 shares
CY2024Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9021000 usd
CY2024 WEWA Effective Income Tax Rate Reconciliation At Federal Statutory Income Taxes Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxesRate
0.21 pure
CY2023 WEWA Effective Income Tax Rate Reconciliation At Federal Statutory Income Taxes Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxesRate
0.21 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0 pure
CY2024 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.21 pure
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1894000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1869000 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1894000 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1869000 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1894000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1869000 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-001330-index-headers.html Edgar Link pending
0001079973-24-001330-index.html Edgar Link pending
0001079973-24-001330.txt Edgar Link pending
0001079973-24-001330-xbrl.zip Edgar Link pending
ex31x1.htm Edgar Link pending
ex32x1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wewa-20240531.xsd Edgar Link pending
wewa_10k-053124.htm Edgar Link pending
wewa-20240531_cal.xml Edgar Link unprocessable
wewa-20240531_def.xml Edgar Link unprocessable
wewa-20240531_pre.xml Edgar Link unprocessable
wewa-20240531_lab.xml Edgar Link unprocessable
wewa_10k-053124_htm.xml Edgar Link completed